Table 1.
Baseline characteristics grouped according to outcomes during follow-up.
|
Overall (n = 84) |
No DoCE (n = 70) |
DoCE (n = 14) |
P -value* | |
|---|---|---|---|---|
| Age (years ± SD) | 62 ± 11 | 62 ± 11 | 63 ± 6 | 0.43 |
| Males, n (%) | 63 (75) | 50 (71) | 13 (93) | 0.09 |
| Presentation, n (%) | 0.71 | |||
| CCS | 28 (34) | 22 (31) | 6 (43) | |
| UA/ NSTEMI | 34 (40) | 29 (41) | 5 (36) | |
| STEMI | 22 (26) | 19 (27) | 3 (21) | |
| Heart rate (bpm ± SD) | 73 ± 16 | 71 ± 16 | 82 ± 17 | 0.01 |
| Systolic blood pressure (mmHg ± SD) | 115 ± 21 | 115 ± 20 | 119 ± 22 | 0.27 |
| Diastolic blood pressure (mmHg ± SD) | 72 ± 16 | 71 ± 16 | 76 ± 8 | 0.14 |
| Left ventricular ejection fraction, n (%) | 57 ± 10 | 57 ± 10 | 57 ± 11 | 0.48 |
| Creatinine (mmol/L ± SD) | 83 ± 23 | 83 ± 25 | 79 ± 10 | 0.31 |
| Arterial hypertension n (%) | 49 (58) | 40 (57) | 9 (64) | 0.62 |
| Diabetes mellitus n (%) | 10 (12) | 8 (11) | 2 (14) | 0.76 |
| Dyslipidemia, n (%) | 44 (52) | 35 (50) | 9 (64) | 0.33 |
| Current smoking, n (%) | 43 (51) | 35 (50) | 8 (57) | 0.62 |
| Family history of premature CAD, n (%) | 24 (29) | 19 (27) | 5 (36) | 0.52 |
| Previous MI, n (%) | 19 (23) | 15 (21) | 4 (29) | 0.56 |
| Previous CABG, n (%) | 3 (3.6) | 2 (2.9) | 1 (7.1) | 0.43 |
| Antithrombotics, n (%) | ||||
| Aspirin | 83 (99) | 69 (99) | 14 (100) | - |
| Clopidogrel | 36 (43) | 30 (43) | 6 (43) | 1.00 |
| Ticagrelor | 33 (39) | 27 (39) | 6 (43) | 0.76 |
| Prasugrel | 14 (17) | 13 (19) | 1 (7.1) | 0.29 |
| Direct oral anticoagulant | 3 (3.6) | 2 (2.9) | 1(7.1) | 043 |
| GPIIbIIIa inhibitor | 41 (49) | 33 (47) | 8 (57) | 0.49 |
| Access, n (%) | 0.32 | |||
| Radial | 72 (86) | 62 (89) | 10 (71) | |
| Femoral | 12 (14) | 9 (13) | 3 (21) | |
Data are mean (standard deviation) or number (percentage), as appropriate.
Bpm, Beats per minute; CCS, chronic coronary artery syndrome; CAD, Coronary artery disease; CABG, Coronary artery bypass grafting; DoCE, device-oriented composite endpoint; GPIIbIIIa, Glycoprotein IIbIIIa; MI, Myocardial infarction; NSTEMI, Non-ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; UA, Unstable angina.
*
P-values were based on student's t-tests, Fisher's test or Chi-square tests, as appropriate.